Oral Candidiasis

• CLINICAL_TRIALS trial_result · 2008-06-26
  Clinical Trial Update: Phase 2B Dose-Ranging Study of PAC113 Mouthrinse in HIV Seropositive Individuals With Oral Candidiasis [Phase 2]

  This document reports the completion of a Phase 2B dose-ranging study evaluating PAC113 mouthrinse for oral candidiasis in HIV-seropositive …

• CLINICAL_TRIALS trial_result · 2008-03-04
  Clinical Trial Update: A Randomized, Double-Blind, Placebo Controlled Trial Evaluating the Impact of Nystatin on the Development of Oral Irritation in Patients Receiving High Dose Intravenous Interleukin-2 [Phase 3]

  Phase 3 randomized trial evaluating whether Nystatin reduces oral irritation in patients receiving high-dose intravenous interleukin-2; the …

• CLINICAL_TRIALS trial_result · 2008-03-04
  Clinical Trial Update: Fluconazole Prophylaxis of Thrush in AIDS [Phase 4]

  This update reports the completion of a Phase 4 trial evaluating fluconazole as prophylaxis against thrush in people with AIDS. The study fo…

• CLINICAL_TRIALS trial_result · 2008-03-04
  Clinical Trial Update: The Effect of Oral Candidiasis on the Speech Production, Feeding Skills, and Self-Concept of Children and Adolescents With Symptomatic HIV Infection

  This clinical trial update examines how oral candidiasis affects speech production, feeding skills, and self-concept in children with sympto…

• CLINICAL_TRIALS trial_result · 2007-10-02
  Clinical Trial Update: Nystatin Pastilles for the Prevention of Oral Candidiasis in Patients With AIDS or ARC [NA]

  Clinical trial evaluating nystatin pastilles to prevent oral candidiasis in patients with AIDS or ARC has completed.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2007-10-02
  Clinical Trial Update: A Study of Nystatin in the Prevention of Fungal Infections of the Mouth in Patients With AIDS or AIDS-Related Syndromes [NA]

  This is a completed clinical trial sponsored by Bristol-Myers Squibb evaluating nystatin for prevention of oral candidiasis in patients with…

• FDA approval · 2007-09-10
  FDA Approved: CLOTRIMAZOLE — Supplemental Application (Padagis US LLC)

  FDA approved a supplemental application for clotrimazole by Padagis US LLC.